Cargando…

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study

BACKGROUND: Patients with peripheral arterial disease (PAD) often remain undiagnosed and therefore suboptimally managed. Here, we investigated the diagnostic and prognostic potential of fatty acid binding protein 3 (FABP3) in patients with PAD. METHODS: In the discovery phase, 374 PAD and 184 non-PA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamzam, Abdelrahman, Syed, Muzammil H., Rotstein, Ori D., Eikelboom, John, Klein, David J., Singh, Krishna K., Abdin, Rawand, Qadura, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755058/ https://www.ncbi.nlm.nih.gov/pubmed/36531981 http://dx.doi.org/10.1016/j.eclinm.2022.101766

Ejemplares similares

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Zamzam, Abdelrahman, et al.
Publicado: (2021)

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Perceived Challenges to Routine Uptake of the Ankle Brachial Index within Primary Care Practice
por: Chiu, Lily Y. C., et al.
Publicado: (2021)

The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events
por: Li, Ben, et al.
Publicado: (2022)

Angiogenesis-related proteins as biomarkers for peripheral artery disease
por: Li, Ben, et al.
Publicado: (2023)

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
por: Ehsan, Mehroz, et al.
Publicado: (2022)

The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
por: Arfan, Sara, et al.
Publicado: (2022)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease
por: Alsuwailem, Bader, et al.
Publicado: (2021)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
por: Feridooni, Tiam, et al.
Publicado: (2022)

Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Increasing Awareness for Peripheral Artery Disease through the Identification of Novel Biomarkers
por: Li, Ben, et al.
Publicado: (2023)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021)

Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review
por: Nguyen, Hien C., et al.
Publicado: (2020)

A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease
por: Djahanpour, Niousha, et al.
Publicado: (2023)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
por: Khan, Hamzah, et al.
Publicado: (2022)

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020)

Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report
por: Syed, Muzammil H., et al.
Publicado: (2021)

Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature
por: Khan, Hamzah, et al.
Publicado: (2023)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
por: Murugavel, Shamini, et al.
Publicado: (2018)

A novel Canadian multidisciplinary acute care pathway for people hospitalised with a diabetic foot ulcer
por: Zamzam, Abdelrahman, et al.
Publicado: (2023)

Circulating cytokines in predicting development of severe acute pancreatitis
por: Rotstein, Ori D
Publicado: (2014)

Loss of fatty acid binding protein 3 ameliorates lipopolysaccharide-induced inflammation and endothelial dysfunction
por: Nguyen, Hien C., et al.
Publicado: (2023)

Engineered Production of Short Chain Fatty Acid in Escherichia coli Using Fatty Acid Synthesis Pathway
por: Jawed, Kamran, et al.
Publicado: (2016)

Improved SARS-CoV-2 PCR detection and genotyping with double-bubble primers
por: Ailenberg, Menachem, et al.
Publicado: (2021)

The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance
por: Al Fayi, Majed Saad, et al.
Publicado: (2016)

Diagnostic and prognostic significance of peripheral blood cultural characteristics in adult acute leukaemia.
por: Balkwill, F. R., et al.
Publicado: (1976)

Diagnostic and prognostic value of the peripheral natural killer cell levels in gastric cancer
por: Chen, Yu-Yan, et al.
Publicado: (2020)

Dietary fatty acids and inflammatory markers in patients with coronary artery disease
por: Niknam, Mahdieh, et al.
Publicado: (2014)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms
por: Peng, Xiaoxue, et al.
Publicado: (2017)

Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study
por: Szyszkowska, Anna, et al.
Publicado: (2022)

Peri-operative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery
por: Schaub, Jennifer A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7vt864i84i4u85425e4jnq4m2q